Japan Price-Setting Decision Frees Drug Makers To Release Generics
This article was originally published in PharmAsia News
Executive Summary
Armed with government-set prices, several makers of generic drugs in Japan plan to launch anti-cancer drugs through the rest of the year. Sawai Pharmaceutical released 34 as soon as the Health Ministry announced official prices, and Towa Pharmaceutical plans to introduce 14 over the next few weeks. Nichi-Iko Pharmaceutical says it plans to release 26 generics over the course of the year and Taiyo Pharmaceutical Industry plans 17. (Click here for more - a subscription may be required